• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Treatment strategies for co-occurring ADHD and substance use disorders.注意缺陷多动障碍（ADHD）与物质使用障碍共病的治疗策略
Am J Addict. 2007;16 Suppl 1(Suppl 1):45-54; quiz 55-6. doi: 10.1080/10550490601082783.
2
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].[关于同时患有注意力缺陷多动障碍和物质使用障碍的青少年筛查、诊断和治疗的国际共识声明]
Z Kinder Jugendpsychiatr Psychother. 2021 Jan;50(1):54-67. doi: 10.1024/1422-4917/a000828. Epub 2021 Aug 16.
3
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.对多动症合并物质使用障碍患者使用精神刺激药物所产生问题的定性综述。
Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908x280707. Epub 2008 Apr 1.
4
The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.注意缺陷多动障碍与物质使用障碍之间复杂的关系。
Curr Psychiatry Rep. 2014 Mar;16(3):436. doi: 10.1007/s11920-013-0436-6.
5
[Recommendations for the screening, diagnosis and treatment of patients with comorbid attention deficit hyperactivity- and substance use disorder].[注意缺陷多动障碍与物质使用障碍共病患者的筛查、诊断和治疗建议]
Psychiatr Hung. 2020;35(4):435-447.
6
International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder.国际物质使用障碍共病注意缺陷/多动障碍患者筛查、诊断和治疗共识声明。
Eur Addict Res. 2018;24(1):43-51. doi: 10.1159/000487767. Epub 2018 Mar 6.
7
Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.在存在物质使用障碍的情况下管理注意力缺陷/多动障碍。
J Clin Psychiatry. 2007;68 Suppl 11:23-30.
8
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.青少年物质使用多动障碍（ADHD）多模式治疗研究（MTA）作为儿童 ADHD、随机分配到儿童治疗和随后药物治疗的功能。
J Am Acad Child Adolesc Psychiatry. 2013 Mar;52(3):250-63. doi: 10.1016/j.jaac.2012.12.014. Epub 2013 Feb 8.
9
Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.注意缺陷多动障碍与物质使用障碍治疗寻求者的全球严重程度特征。
Eur Addict Res. 2020;26(4-5):201-210. doi: 10.1159/000508546. Epub 2020 Jun 22.
10
Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.患有物质使用障碍（SUD）并伴有注意力缺陷/多动障碍（ADHD）或自闭症谱系障碍（ASD）的成年患者使用物质对日常生活的影响：患者视角
BMC Psychiatry. 2014 Sep 19;14:264. doi: 10.1186/s12888-014-0264-1.

引用本文的文献

1
The long way to diagnosis: attention disorder, alcohol addiction or congenital disorder of glycosylation? A case report.诊断的漫漫长路：注意缺陷障碍、酒精成瘾还是先天性糖基化障碍？一例报告
BMC Psychiatry. 2025 Apr 29;25(1):435. doi: 10.1186/s12888-025-06862-9.
2
Assessing willingness and preference for body scan practices in ADHD: a survey study.评估注意力缺陷多动障碍患者对身体扫描检查的意愿和偏好：一项调查研究。
BMC Complement Med Ther. 2025 Mar 29;25(1):120. doi: 10.1186/s12906-025-04842-w.
3
Sex differences in psychiatric comorbidities of attention-deficit/hyperactivity disorder among children, adolescents, and adults: A nationwide population-based cohort study.儿童、青少年和成人注意力缺陷多动障碍精神共病的性别差异：一项基于全国人群的队列研究。
PLoS One. 2025 Jan 3;20(1):e0315587. doi: 10.1371/journal.pone.0315587. eCollection 2025.
4
Attention Deficit Hyperactivity Disorder: A Risk Factor for Premature Discontinuation of Inpatient Opioid Withdrawal Treatment.注意缺陷多动障碍：住院阿片类药物戒断治疗过早停药的一个风险因素。
J Clin Med. 2024 Jun 3;13(11):3301. doi: 10.3390/jcm13113301.
5
The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.美国酒精滥用与药物依赖协会/美国成瘾医师协会临床实践指南：兴奋剂使用障碍管理
J Addict Med. 2024;18(1S Suppl 1):1-56. doi: 10.1097/ADM.0000000000001299.
6
Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations.物质使用障碍培训，第1部分：临床实践建议概述。
Can J Psychiatry. 2024 Jun;69(6):428-456. doi: 10.1177/07067437241231128. Epub 2024 Apr 13.
7
The effects of tryptophan loading on Attention Deficit Hyperactivity in adults: A remote double blind randomised controlled trial.色氨酸负荷对成人注意缺陷多动障碍的影响：一项远程双盲随机对照试验。
PLoS One. 2023 Nov 30;18(11):e0294911. doi: 10.1371/journal.pone.0294911. eCollection 2023.
8
Identification and treatment of individuals with attention-deficit/hyperactivity disorder and substance use disorder: An expert consensus statement.注意缺陷/多动障碍与物质使用障碍患者的识别与治疗：专家共识声明
World J Psychiatry. 2023 Mar 19;13(3):84-112. doi: 10.5498/wjp.v13.i3.84.
9
The Effects of Different Exercise Approaches on Attention Deficit Hyperactivity Disorder in Adults: A Randomised Controlled Trial.不同运动方式对成人注意力缺陷多动障碍的影响：一项随机对照试验
Behav Sci (Basel). 2023 Feb 2;13(2):129. doi: 10.3390/bs13020129.
10
Prevalence of Attention Deficit Hyperactivity Disorder (ADHD) among Substance Use Disorder (SUD) Populations: Meta-Analysis.物质使用障碍（SUD）人群中注意缺陷多动障碍（ADHD）的患病率：荟萃分析。
Int J Environ Res Public Health. 2023 Jan 10;20(2):1275. doi: 10.3390/ijerph20021275.

本文引用的文献

1
Limitations of the application of fourfold table analysis to hospital data.四格表分析在医院数据应用中的局限性。
Biometrics. 1946 Jun;2(3):47-53.
2
Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.对患有成人注意力缺陷多动障碍的可卡因依赖治疗寻求者的治疗：哌甲酯与安慰剂的双盲比较。
Drug Alcohol Depend. 2007 Feb 23;87(1):20-9. doi: 10.1016/j.drugalcdep.2006.07.004. Epub 2006 Aug 22.
3
A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.莫达非尼每日一次与分次给药治疗儿童注意缺陷/多动障碍的比较：一项随机、双盲、安慰剂对照研究。
J Clin Psychiatry. 2006 May;67(5):727-35. doi: 10.4088/jcp.v67n0506.
4
Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder.患有和未患有注意力缺陷/多动障碍的青少年物质使用起始的行为预测因素。
Pediatrics. 2006 Jun;117(6):2030-9. doi: 10.1542/peds.2005-0704.
5
Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications.转移或滥用处方药的多动症青少年及青年的特征。
J Am Acad Child Adolesc Psychiatry. 2006 Apr;45(4):408-14. doi: 10.1097/01.chi.0000199027.68828.b3.
6
A randomized, double-blind, placebo-controlled study of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder.一项关于莫达非尼薄膜包衣片用于治疗儿童和青少年注意力缺陷/多动障碍的随机、双盲、安慰剂对照研究。
J Am Acad Child Adolesc Psychiatry. 2006 May;45(5):503-511. doi: 10.1097/01.chi.0000205709.63571.c9.
7
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.美国成人注意力缺陷多动障碍的患病率及其相关因素：全国共病调查复制研究的结果
Am J Psychiatry. 2006 Apr;163(4):716-23. doi: 10.1176/ajp.2006.163.4.716.
8
PET study examining pharmacokinetics, detection and likeability, and dopamine transporter receptor occupancy of short- and long-acting oral methylphenidate.一项正电子发射断层扫描（PET）研究，考察短效和长效口服哌醋甲酯的药代动力学、检测及亲和性，以及多巴胺转运体受体占有率。
Am J Psychiatry. 2006 Mar;163(3):387-95. doi: 10.1176/appi.ajp.163.3.387.
9
Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation.莫达非尼薄膜包衣片用于治疗儿童和青少年注意力缺陷多动障碍：一项随机、双盲、安慰剂对照、固定剂量研究及突然停药后的结果
J Clin Psychiatry. 2006 Jan;67(1):137-47. doi: 10.4088/jcp.v67n0120.
10
Cognitive deficits predict low treatment retention in cocaine dependent patients.认知缺陷预示着可卡因依赖患者的低治疗保留率。
Drug Alcohol Depend. 2006 Feb 28;81(3):313-22. doi: 10.1016/j.drugalcdep.2005.08.003. Epub 2005 Sep 19.

注意缺陷多动障碍（ADHD）与物质使用障碍共病的治疗策略

Treatment strategies for co-occurring ADHD and substance use disorders.

作者信息

Mariani John J, Levin Frances R

机构信息

New York State Psychiatric Institute, New York, New York, USA.

出版信息

Am J Addict. 2007;16 Suppl 1(Suppl 1):45-54; quiz 55-6. doi: 10.1080/10550490601082783.

DOI:10.1080/10550490601082783
PMID:17453606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2676785/
Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common co-occurring mental disorder among patients with substance use disorders (SUD). Clinicians must be cognizant of the complicated nature of diagnosis and treatment of ADHD when comorbid with SUD. Pharmacotherapy remains the mainstay of treatment for ADHD, although complementary psychotherapeutic approaches have been developed. Psychostimulant medications are the most commonly used medications to treat ADHD, but many clinicians are reluctant to prescribe stimulants to patients with SUD. Recommendations for treatment planning and clinical management for patients with co-occurring ADHD and SUD are discussed.

摘要

注意缺陷多动障碍（ADHD）是物质使用障碍（SUD）患者中常见的共病精神障碍。临床医生在面对ADHD与SUD共病情况时，必须认识到其诊断和治疗的复杂性。药物治疗仍然是ADHD治疗的主要方法，尽管也已开发出辅助心理治疗方法。精神刺激药物是治疗ADHD最常用的药物，但许多临床医生不愿给患有SUD的患者开此类药物。本文讨论了ADHD与SUD共病患者的治疗计划和临床管理建议。